FibroBiologics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
FibroBiologics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2024.
  • FibroBiologics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$3.1M, a 68.1% increase year-over-year.
  • FibroBiologics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$11.2M, a 32.3% increase year-over-year.
  • FibroBiologics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$11.2M, a 32.3% increase from 2023.
  • FibroBiologics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$16.5M, a 222% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.2M +$5.32M +32.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$16.5M -$11.4M -222% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$5.12M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.